Title: Salmeterol Response is Not Affected by Beta2-adrenergic Receptor Genotype in Patients with Persistent Asthma
Abstract: PURPOSE: To evaluate clinical responses to the inhaled long-acting beta2-agonist (LABA), salmeterol, administered with fluticasone propionate (FP) in asthma patients with differing ADRB2 polymorphisms at codon 16.